Searched for
GREENSIGNAL BIO PHARMA
War, dividend yield, and trading: 5 stocks with a dividend yield of up to 4.6%; 4 with an upside potential of up to 36%Once you have confirmed that the yield spike is genuine and the dividend is safe, the trade set-up is about patience, not speed. That gap b...- Independence Day 2025: PM Modi's full speechPrime Minister Modi addressed the nation on the 79th Independence Day, highlighting India's progress towards self-reliance and development....
- Sheela Foam IPO sees subscription of five times on last dayData showed there was brisk buying by qualified institutional investors (QIBs), whose quota limit was subscribed by over 4 times.
- Sheela Foam gathers pace, subscribed 28%; issue closes todayData showed there was brisk buying by qualified institutional investors (QIBs), whose quota limit was subscribed 79 per cent.
- Sheela Foam receives poor response, subscribed 0.9% on Day 1The offer received bids for 76,780 shares as against 52,50,001 shares on offer, which are available in the price band of Rs 680-730 apiece.
- Sheela Foam IPO kicks off after Rs 153-crore anchor allotment; brokers' viewThe issue is an offer for sale (OFS) wherein existing promoter entity is looking to offload its 27.75 per cent holding in the mattress comp...
- Rs 510 crore Sheela Foam IPO to hit market tomorrow: Should you buyThe issue is an offer for sale (OFS), wherein existing promoter entity Polyflex Marketing is looking to offload its 27.75 per cent holding ...
- GreenSignal Bio withdraws Rs 112-cr IPOConsidering the issue as undersubscribed, the merchant banker along with the company will start the process of unblocking funds.
- Key market triggers to watch out before Opening BellNifty50 futures on the Singapore Stock Exchange were trading 66 points higher at 8,056, indicating a higher opening for the domestic market.
- Varun Beverages, GreenSignal Bio issues add depression to otherwise buoyant IPO martFirst it was the poor debut for Varun Beverages (VBL) and then came the IPO of GreenSignal Bio, which did not get the required bids during ...
- Mapping the market: 76 BSE stocks at 52-week low, smallcaps hit hardIt was a Black Friday for the domestic equity market, which saw the BSE benchmark Sensex clock its second-biggest percentage fall of 2016.
- GreenSignal Bio IPO subscribed 0.8 times on Day 3; issue extended till Nov 17Data showed non-institutional investors subscribed to just 12 per cent of the quota limit of 21,86,934 shares while retail individual inves...
- GreenSignal Bio Pharma IPO sees tepid demand on Day 3, subscribed 0.61 timesData showed non-institutional investors subscribed to just 10 per cent of the quota limit of 21,86,934 shares while RIIs bade for 5.98 time...
- GreenSignal Bio Pharma IPO subscribed 16% on day 2The portion set aside for non institutional investors was subscribed 2 per cent, while that of retail investors got oversubscribed 1.59 tim...
- GreenSignal Bio Pharma fixes price band of Rs 76-80 for IPOGSBPL is one of the four companies worldwide who have been WHO-prequalified to supply the BCG vaccine to UNICEF.
- Government clears KKR's proposal to buy stakes in Gland Pharma and Gland Celsus Bio ChemicalsGland Pharma makes and markets specialised injectable formulations for generic versions of drugs, it also manufactures a limited quantity o...
- KKR-Gland Pharma deal gets Competition Commission nodCompetition Commission of India (CCI) has given nod for the proposal, which involves multiple transactions, saying the deal does not raise ...
- India emerging as leading vaccine manufacturer: Steven MyintIndia had revenue of $ 665 million in this space which was expected to reach $ 800 million soon, said Steven H Myint.
- Aurobindo: Proceeds from stake sale to beef up cash flowsFrom being a low-margin pharma manufacturer, Aurobindo Pharma is transforming itself into a high-margin formulations player.
- India still far from SEZllingET takes a ringside view of the status of SEZs - expected to attract over Rs 40,000 crore in five years.
Load More
